A number of Latin American countries have reportedly experienced extremely aggressive negotiating tactics by US pharmaceutical giant Pfizer, which has demanded full immunity from any civil claims and state assets as a guarantee.
As Indonesia prepares to begin mass inoculations against COVID-19, its plan to prioritise working age adults over the elderly, aiming to reach herd immunity fast and revive the economy, will be closely watched by other countries.
The US Food and Drug Administration (FDA) is working with the Centres for Disease Control and Prevention (CDC) to find the culprit behind reports of allergic reactions to the Pfizer/BioNTech Covid-19 vaccine.
U.S. Pharma giant Pfizer and its German partner BioNTech said on Wednesday that documents related to development of their COVID-19 vaccine had been “unlawfully accessed” in a cyberattack on Europe’s medicines regulator.
The European Union could pay more than $10 billion to secure hundreds of millions of doses of the vaccine candidates being developed by Pfizer-BioNTech and CureVac, an EU official involved in the talks told Reuters.
Britain has formally asked its medical regulator, to assess the Pfizer-BioNTech COVID-19 vaccine for its suitability, the first step in making the shot available outside of the United States.